Is a continuous glucose monitoring patch contraindicated for MRI (magnetic resonance imaging)?

CGM Devices and MRI: Removal Required

Continuous glucose monitoring (CGM) patches should be removed before MRI procedures according to current manufacturer guidelines and clinical practice recommendations. 1, 2, 1

Key Clinical Guidance

Multiple clinical guidelines consistently state that glucose monitoring devices must be removed for certain radiological procedures, specifically including MRI 1. This recommendation applies across all CGM types, including:

• Real-time CGM systems (Dexcom, Medtronic)
• Intermittently scanned CGM (Abbott FreeStyle Libre)
• Implantable CGM devices (Senseonics Eversense)

The Chinese Clinical Guidelines for CGM (2019) explicitly state that patients wearing CGM systems should avoid exposure to strong magnetic fields and MRI examinations 2.

Why This Matters for Patient Safety

The contraindication exists due to several safety concerns:

• Displacement force: During 3T MRI, CGM devices experience significant displacement forces (up to 306g for some devices), though research suggests this may be insufficient to dislodge sensors 3
• RF-induced heating: Minimal heating (<2°C) can occur during MRI procedures 3
• Magnetic field interference: Strong magnetic fields can potentially affect device function and data integrity
• Manufacturer liability: Each company maintains specific lists of contraindicated procedures 1

Important Nuances from Recent Research

While guidelines mandate removal, emerging research challenges this absolute contraindication:

• Laboratory studies show CGM components (Dexcom G6, FreeStyle Libre systems) retain basic functionality and data integrity after simulated MRI exposure at both 1.5T and 3T 3, 4
• Real-world data demonstrates CGM accuracy remains intact when devices stay outside the field of view during diagnostic imaging 5
• Displacement forces measured in testing are over 100× smaller than forces required to dislodge sensors from the body 4

Clinical Algorithm for Management

Before MRI scheduling:

1. Identify all patients with CGM devices during pre-screening using standardized checklists 6
2. Document the specific CGM brand and model
3. Coordinate with the patient's diabetes care team

Day of MRI:

1. Remove the CGM sensor and transmitter before entering the MRI suite 1, 2
2. Provide alternative glucose monitoring (fingerstick glucometer) during the MRI period
3. Replace CGM after MRI completion per manufacturer instructions

For insulin pump users: Note that insulin pumps also require removal for MRI, creating additional diabetes management challenges 1

Common Pitfalls to Avoid

• Don't assume all imaging is contraindicated: X-ray and CT scanning do NOT require CGM removal based on current evidence 3, 4, 5
• Don't leave patients without glucose monitoring: Provide fingerstick supplies and clear instructions for the MRI period
• Don't forget to document: Record CGM removal and replacement in the medical record
• Don't ignore manufacturer updates: Guidelines may evolve as newer devices receive MRI-conditional labeling

The Evidence Gap

There's a notable disconnect between manufacturer warnings (which mandate removal) and emerging research data (which suggests devices may tolerate MRI exposure). Until manufacturers update their labeling and regulatory approval includes MRI-conditional status, the standard of care remains removal before MRI 1, 2, 1. This conservative approach prioritizes patient safety and medicolegal protection while the evidence base continues to develop.

For diathermy procedures, the same removal requirement applies 1.